Rare Disease Report

Venetoclax and Acute Myeloid Leukemia

DECEMBER 08, 2016
Andrew Wei, MD

Albert Wei of the Alfred Hospital and Monash University in Melbourne, Australia talks about the use of venetoclax plus low-dose cytarabine to treat elderly patients with acute myeloid leukemia. The study found the drug to be safe and clinical remission was achieved in the majority of patients.


Wei A, Strickland SA, Roboz GJ,  et al.  Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged ≥65 Years with Acute Myeloid Leukemia. Presented at the 58th Annual ASH Meeting & Exposition; San Diego, CA; December 3-6, 2016. Abstract 102

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.